Does concurrent splenectomy at colorectal cancer resection influence survival?

Area of Science:

• Surgical Oncology
• Gastrointestinal Surgery
• Infectious Disease

Background:

• Splenectomy is sometimes performed concurrently with colorectal cancer resection.
• The impact of concurrent splenectomy on postoperative outcomes and survival in colorectal cancer patients is not well-established.

Purpose of the Study:

• To investigate the association between concurrent splenectomy and colorectal cancer resection with postoperative complications and long-term survival.

Main Methods:

• A retrospective case-control study matched 21 patients who underwent concurrent splenectomy with colorectal cancer resection to control patients.
• Matching criteria included age, sex, tumor site, Dukes stage, tumor differentiation, and operation date.
• Postoperative infective complications, overall survival, and disease-free survival were compared between groups.

Main Results:

• Patients undergoing concurrent splenectomy had significantly higher rates of postoperative infective complications (11 vs. 4, P = 0.03).
• Five-year overall survival rates did not differ significantly (45% vs. 59%, P = 0.24).
• Five-year disease-free survival for Dukes B and C cancers also showed no significant difference (P > 0.25).

Conclusions:

• Concurrent splenectomy during colorectal cancer resection is associated with an increased risk of postoperative sepsis.
• Splenectomy does not appear to negatively affect long-term overall or disease-free survival in these patients.
• The low incidence of concurrent splenectomy may limit the statistical power to detect survival differences (Type II error).